other material
confidence high
sentiment neutral
materiality 0.60
ZyVersa raises ~$1.7M via warrant exercise inducement at $2.06/share
ZyVersa Therapeutics, Inc.
- Existing warrant holders exercise at reduced price of $2.06/share; gross proceeds ~$1.7M.
- Company issues new Series A-2 warrants for 200% of exercised shares, exercise price $2.06, 5-year term.
- Engaged A.G.P./Alliance Global Partners as financial advisor; cash fee $110,000 plus $10k expenses.
- Net proceeds for working capital and general corporate purposes.
- Company to file resale registration statement for new warrant shares by Dec 20, 2024.